Mental, behavioral and neurodevelopmental disorders in the ICD-11: an international perspective on key changes and controversies
- PMID: 31983345
- PMCID: PMC6983973
- DOI: 10.1186/s12916-020-1495-2
Mental, behavioral and neurodevelopmental disorders in the ICD-11: an international perspective on key changes and controversies
Abstract
An update of the chapter on Mental, Behavioral and Neurodevelopmental Disorders in the International Classification of Diseases and Related Health Problems (ICD) is of great interest around the world. The recent approval of the 11th Revision of the ICD (ICD-11) by the World Health Organization (WHO) raises broad questions about the status of nosology of mental disorders as a whole as well as more focused questions regarding changes to the diagnostic guidelines for specific conditions and the implications of these changes for practice and research. This Forum brings together a broad range of experts to reflect on key changes and controversies in the ICD-11 classification of mental disorders. Taken together, there is consensus that the WHO's focus on global applicability and clinical utility in developing the diagnostic guidelines for this chapter will maximize the likelihood that it will be adopted by mental health professionals and administrators. This focus is also expected to enhance the application of the guidelines in non-specialist settings and their usefulness for scaling up evidence-based interventions. The new mental disorders classification in ICD-11 and its accompanying diagnostic guidelines therefore represent an important, albeit iterative, advance for the field.
Keywords: Classification; Diagnosis; ICD-11; Mental disorder.
Conflict of interest statement
DJS has received research grants or consultancy honoraria from Lundbeck and Sun.
MB has received Grant/Research Support from the NIH, Cooperative Research Centre, Simons Autism Foundation, Cancer Council of Victoria, Stanley Medical Research Foundation, Medical Benefits Fund, National Health and Medical Research Council, Medical Research Futures Fund, Beyond Blue, Rotary Health, A2 milk company, Meat and Livestock Board, Woolworths, Avant and the Harry Windsor Foundation, has been a speaker for Astra Zeneca, Lundbeck, Merck, Pfizer, and served as a consultant to Allergan, Astra Zeneca, Bioadvantex, Bionomics, Collaborative Medicinal Development, Lundbeck Merck, Pfizer and Servier.
MM has chaired the ICD-11 Working Group on Mood and Anxiety Disorders and has been a member of the DSM-5 Work Group on Mood Disorders. Apart from this, he has no potential conflicts of interests to declare.
AMR, PdJ, PB, PS, and YAdV declare that they have no competing interests.
EV has received grants and served as consultant, advisor or CME speaker for the following entities: AB-Biotics, Abbott, Allergan, Angelini, Dainippon Sumitomo Pharma, Galenica, Janssen, Lundbeck, Novartis, Otsuka, Sage, Sanofi-Aventis, and Takeda.
KMP reports no conflicts or competing interests. She served on the Culture Consultation Group for the DSM-5. She has received funds from Shire Pharmaceutical for an independent investigator research study.
CMG reports no conflicts or competing interests but reports several broader interests, which, however, did not influence this paper, including Consultant to Sunovion and Weight Watchers International, honoraria for lectures, CME activities and presentations at scientific conferences, and royalties from Guilford Press and Taylor & Francis Publishers for academic books.
NAF has received personal fees from Sun, Abbott, Lundbeck, Taylor and Francis, and Oxford University Press; personal fees and non-financial support from Otsuka-Lundbeck, the MHRA, the BAP, the RANZCP, and Wiley; grants and non-financial support from the EU, ECNP, and Shire; non-financial support from the Indian Association of Biological Psychiatry, WHO, CINP, International Forum of Mood and Anxiety Disorders, International College of Obsessive Compulsive Spectrum Disorders, and RCPsych; and grants and non-financial support from the NIHR, MRC, and Wellcome.
PTC-K was chair of the Gender Identity Disorders Subworking Group of the DSM-5.
WG was a Member of the APA Working Group on Psychotic Disorders. He was a Member of the WHO Topic Advisory Group on Mental and Behavioral Disorders, and he is a Member of the Field Study Coordination Group, of the WHO FIC ICD-11 Medical and Scientific Advisory Committee, and of the WHO Advisory Group on the Implementation of ICD-11.
AM, CRB, DJS, WG, MM, AM, KMP, NAF, PB, and PTC-K were members of the International Advisory Group and/or Expert Working Groups involved in the development of ICD-11 Mental, Behavioral or Neurodevelopmental Disorders. GMR is a member of the WHO Secretariat, Department of Mental Health and Substance Abuse. He has no competing interests pertaining to this submission.
Figures

















Similar articles
-
Letter to the Editor: CONVERGENCES AND DIVERGENCES IN THE ICD-11 VS. DSM-5 CLASSIFICATION OF MOOD DISORDERS.Turk Psikiyatri Derg. 2021;32(4):293-295. doi: 10.5080/u26899. Turk Psikiyatri Derg. 2021. PMID: 34964106 English, Turkish.
-
The classification of feeding and eating disorders in the ICD-11: results of a field study comparing proposed ICD-11 guidelines with existing ICD-10 guidelines.BMC Med. 2019 May 14;17(1):93. doi: 10.1186/s12916-019-1327-4. BMC Med. 2019. PMID: 31084617 Free PMC article. Clinical Trial.
-
[ICD-11: New revision and impact of this classification in psychiatry].Encephale. 2024 Jun;50(3):329-338. doi: 10.1016/j.encep.2023.10.003. Epub 2023 Dec 12. Encephale. 2024. PMID: 38092593 Review. French.
-
Changes from ICD-10 to ICD-11 and future directions in psychiatric classification .Dialogues Clin Neurosci. 2020 Mar;22(1):7-15. doi: 10.31887/DCNS.2020.22.1/wgaebel. Dialogues Clin Neurosci. 2020. PMID: 32699501 Free PMC article. Review.
-
Letter to the Editor: EDUCATIONAL ACTIVITIES RELATED TO THE ICD-11 CHAPTER ON MENTAL DISORDERS.Turk Psikiyatri Derg. 2021;32(4):291-292. doi: 10.5080/u26898. Turk Psikiyatri Derg. 2021. PMID: 34964105 English, Turkish.
Cited by
-
Classification, prevalence and integrated care for neurodevelopmental and child mental health disorders: A brief overview for paediatricians.World J Clin Pediatr. 2022 Mar 9;11(2):120-135. doi: 10.5409/wjcp.v11.i2.120. eCollection 2022 Mar 9. World J Clin Pediatr. 2022. PMID: 35433298 Free PMC article. Review.
-
Secular trends in the incidence of major depressive disorder and dysthymia in China from 1990 to 2019.BMC Public Health. 2023 Nov 6;23(1):2162. doi: 10.1186/s12889-023-17025-4. BMC Public Health. 2023. PMID: 37926849 Free PMC article.
-
Existing and emerging pharmacological approaches to the treatment of mania: A critical overview.Transl Psychiatry. 2022 Apr 23;12(1):169. doi: 10.1038/s41398-022-01928-8. Transl Psychiatry. 2022. PMID: 35461339 Free PMC article. Review.
-
Problematic use of the internet during the COVID-19 pandemic: Good practices and mental health recommendations.Compr Psychiatry. 2022 Jan;112:152279. doi: 10.1016/j.comppsych.2021.152279. Epub 2021 Oct 20. Compr Psychiatry. 2022. PMID: 34700188 Free PMC article. Review.
-
Consensus on nomenclature for clinical staging models in bipolar disorder: A narrative review from the International Society for Bipolar Disorders (ISBD) Staging Task Force.Bipolar Disord. 2021 Nov;23(7):659-678. doi: 10.1111/bdi.13105. Epub 2021 Jul 23. Bipolar Disord. 2021. PMID: 34174130 Free PMC article. Review.
References
-
- Reed GM, Ayuso-Mateos JL. Towards a more clinically useful international World Health Organisation classification of mental disorders. Rev Psiquiatria Salud Ment. 2011;4(3):113–116. - PubMed
-
- Thapar A, Rutter M. Neurodevelopmental disorders. In: Thapar A, Pine DS, Leckman JF, Scott S, Snowling MJ, Taylor E, editors. Rutter’s child and adolescent psychiatry. 6. Oxford: Wiley Blackwell; 2015.
-
- American Psychiatric Association . Diagnostic and statistical manual of mental disorders. 5. Arlington: American Psychiatric Publishing; 2013.